Literature DB >> 25180375

Effects of nutrient restriction and melatonin supplementation on maternal and foetal hepatic and small intestinal energy utilization.

L D Prezotto, C O Lemley, L E Camacho, F E Doscher, A M Meyer, J S Caton, B J Awda, K A Vonnahme, K C Swanson.   

Abstract

To determine how nutrient restriction and melatonin supplementation influence ewe and foetal hepatic and small intestinal energy use, 32 primiparous ewes on d 50 of gestation were fed 60% (RES) or 100% (ADQ) of NRC recommendations with 0 (CON) or 5 mg/d (MEL) of dietary melatonin. On d 130 of gestation, small intestine and liver were weighed and collected. Data were analysed as a completely randomized design with a 2 × 2 factorial arrangement of treatments. Liver weight (g/kg EBW) decreased (p = 0.02) in RES ewes. Jejunum weight (g/kg BW) increased (interaction p = 0.04) in ADQ-MEL ewes compared with all other treatments. Total in vitro O2 consumption (mol/min/tissue) and total citrate synthase activity (mol/min/tissue and mol/min/kg EBW) in liver decreased (p ≤ 0.03) in RES ewes. Oxygen consumption (mol/min/kg EBW) increased (interaction p = 0.02) in jejunum of ADQ-CON versus RES-MEL and ADQ-CON. Citrate synthase activity (mol/min/kg of EBW) increased (interaction p = 0.03) in jejunum of ADQ-MEL compared with RES-MEL and ADQ-CON. Foetal liver weight (g/kg BW) decreased (p = 0.02) in RES versus ADQ. Foetal small intestine weight (g/kg BW) decreased (interaction p = 0.05) in RES-MEL versus ADQ-MEL. Total O2 consumption (mol/min/tissue) and total citrate synthase activity (mol/min/kg of BW) in foetal liver decreased (p ≤ 0.05) in RES versus ADQ. Foetal small intestinal O2 consumption (mol/min/kg of BW) was greater (interaction p = 0.03) in RES-CON and ADQ-MEL than RES-MEL and ADQ-CON. Maternal nutrient restriction had a greater effect than melatonin supplementation on liver and jejunum mass and energy utilization in dams and foetuses. Because intestinal mass and energy utilization were more responsive to melatonin supplementation in ewes fed adequate nutrition compared with restricted ewes, melatonin may have limited use as a therapeutic supplement to help overcome potential negative effects of nutrient restriction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180375     DOI: 10.1111/jpn.12142

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  5 in total

1.  Effects of Nutrient Restriction During Midgestation to Late Gestation on Maternal and Fetal Postruminal Carbohydrase Activities in Sheep.

Authors:  Ronald J Trotta; Manuel A Vasquez-Hidalgo; Kimberly A Vonnahme; Kendall C Swanson
Journal:  J Anim Sci       Date:  2020-01-01       Impact factor: 3.159

Review 2.  Role of the Small Intestine in Developmental Programming: Impact of Maternal Nutrition on the Dam and Offspring.

Authors:  Allison M Meyer; Joel S Caton
Journal:  Adv Nutr       Date:  2016-01       Impact factor: 8.701

Review 3.  The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation.

Authors:  Tina Napso; Hannah E J Yong; Jorge Lopez-Tello; Amanda N Sferruzzi-Perri
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

Review 4.  Prenatal and Postnatal Nutrition Influence Pancreatic and Intestinal Carbohydrase Activities of Ruminants.

Authors:  Ronald J Trotta; Kendall C Swanson
Journal:  Animals (Basel)       Date:  2021-01-13       Impact factor: 2.752

5.  Vitamin and Mineral Supplementation and Rate of Gain in Beef Heifers I: Effects on Dam Hormonal and Metabolic Status, Fetal Tissue and Organ Mass, and Concentration of Glucose and Fructose in Fetal Fluids at d 83 of Gestation.

Authors:  Ana Clara B Menezes; Kacie L McCarthy; Cierrah J Kassetas; Friederike Baumgaertner; James D Kirsch; Sheri T Dorsam; Tammi L Neville; Alison K Ward; Pawel P Borowicz; Lawrence P Reynolds; Kevin K Sedivec; J Chris Forcherio; Ronald Scott; Joel S Caton; Carl R Dahlen
Journal:  Animals (Basel)       Date:  2022-07-08       Impact factor: 3.231

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.